Cargando…
Results of Retrospective Chart Review to Determine Improvement in Lipid Goal Attainment in Patients Treated by High-Volume Prescribers of Lipid-Modifying Drugs
BACKGROUND: There is a primary focus in cholesterol management on the elevated low-density lipoprotein cholesterol (LDL-C) component of dyslipidemia and a secondary focus on the other components of dyslipidemia, such as low high-density lipoprotein cholesterol (HDL-C), high triglycerides (TGs), and...
Autores principales: | Stacy, Thomas A., Egger, Allison |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437990/ https://www.ncbi.nlm.nih.gov/pubmed/17249907 http://dx.doi.org/10.18553/jmcp.2006.12.9.745 |
Ejemplares similares
-
LLDAS is an attainable treat-to-target goal in childhood-onset SLE
por: Wahadat, Mohamed Javad, et al.
Publicado: (2021) -
Prevalence of Dyslipidemia and Lipid Goal Attainment in Statin-Treated Subjects From 3 Data Sources: A Retrospective Analysis
por: Jones, Peter H., et al.
Publicado: (2012) -
Lipid-Lowering Treatment and the Lipid Goals Attainment in Patients with a Very High Cardiovascular Risk
por: Lis, Anna, et al.
Publicado: (2023) -
Factors associated with lipid goal attainment among acute coronary syndrome patients
por: Mohd-Zulkefli, Siti-Zainora, et al.
Publicado: (2016) -
Effect of alirocumab dose increase on LDL lowering and lipid goal attainment in patients with dyslipidemia
por: Kastelein, John J.P., et al.
Publicado: (2017)